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Between 7% and 29% of patients with colorectal carcinoma reportedly present with an acute obstruction requiring emergency treatment (1) . Large bowel obstruction causes colonic dilatation, bacterial translocation, obstructive colitis, and electrolyte and fluid imbalance and poses an increased risk of colonic necrosis and perforation. The main treatment for malignant colonic obstruction includes emergency surgery, a transanal or transnasal ileus tube, or a colonic stent. Emergency surgery for the obstruction is associated with higher morbidity and mortality than elective surgery, and the creation of a stoma is necessary in most cases (2) (3) (4) (5) (6) (7) .
The self-expanding metallic stent (SEMS) was developed for use in palliative treatment or as a bridge to surgery (BTS) for potentially resectable colorectal cancer. As a BTS, SEMS can convert an emergency operation to an elective operation and enable single-stage surgical resection without stoma creation (5, 8, 9) . Several studies have reported that laparoscopic surgery after stent insertion can be performed as safely as open surgery (5, 8, 10) . However, to date, few studies have assessed the influence of SEMS placement on laparoscopic procedures by comparing stent-laparoscopy and regular laparoscopy for non-obstructive colorectal cancer (11) . We began using SEMS in 2012 for the treatment of acute, malignant colonic obstructions covered by the Japanese national health insurance plan. An elective, laparoscopically assisted colorectal cancer resection is used after sufficient decompression of the intestinal tract has been confirmed.
In this study, we aimed to investigate the outcomes of laparoscopic surgery after colonic stent insertion for patients with obstructive colorectal cancer and to compare them with outcomes of regular laparoscopic surgery for patients with non-obstructive colorectal cancer.
Methods
This study was approved by the institutional review board. We conducted a retrospective study of patients who underwent laparoscopic surgery after the insertion of SEMS for obstructive colorectal cancer at a tertiary care hospital in Japan between January 2012 and January 2016. A prospectively maintained database was used to search for eligible patients, and electronic medical records were abstracted for age, gender, tumor location, time interval to operation, type of procedure, perioperative details, and postoperative complications within 30 days of surgery. Postoperative complications were categorized according to the Clavien-Dindo classification (12) .
All patients who needed a SEMS as a BTS presented with abdominal pain, failure to pass gas or feces, the radiological presentation of a dilated colon, and an obstructive lesion on abdominal CT. Tumor location was determined by contrast radiographic findings obtained at the time of stent insertion. Patients were discharged after successful stent insertion and decompression of the bowel and then readmitted 3 weeks after stent insertion.
Preoperative mechanical bowel preparations were done with 5-mg sodium picosulfate hydrate (TEIJIN PHARMA LIMITED., Laxoberon; Tokyo, Japan) 2 days before surgery and a pack (34 g) of magnesium citrate (HORII Pharmaceutical IND., LTD, Magcorol P; Osaka, Japan) dissolved in 180-mL water on the day before surgery. Two experienced colorectal surgeons performed elective laparoscopic resection after SEMS in 25 patients. Of these patients, 10 underwent simultaneous resection of either a colorectal primary and hepatic metastasis or a double primary malignancy in the rectum and transverse colon. Fifteen patients underwent elective laparoscopic surgery for left-sided colorectal cancer. We compared the outcomes of this procedure with those of regular laparoscopic surgery (control group). For the control group, we chose patients who had undergone conventional laparoscopic surgery for stage II, III, or IV nonobstructive left-sided colon and rectal cancer performed by the same surgeons during the study period.
Endoscopic stent placement
Stent placement was performed in eligible patients by colorectal surgeons. After the obstructive lesion was confirmed by flexible colonoscopy, a guide wire was passed through the narrowed lumen under fluoroscopic guidance, followed by a catheter. A water-soluble contrast solution was infused via the catheter to identify the extent of the obstructive lesion. A metallic stent (Niti-S; Taewoong Medical, Seoul, South Korea or WallFlex Colonic Stent; Boston Scientific Corporation, Marlborough, USA) was inserted through the working channel over the guide wire under fluoroscopic guidance. The type and length of the stent were chosen by an endoscopist.
Statistical analysis
Data are presented as mean AE SD for continuous variables and as frequency percentages for categorical variables. The distribution of the data was checked for normality using the Shapiro-Wilk test. These characteristics were analyzed using unpaired Student's t-test (or Mann-Whitney test) for continuous variables and a χ 2 test (or Fisher's exact test) for categorical variables. All tests were two-tailed, and results with a P < 0.05 were considered statistically significant. Statistical analyses were performed using SPSS version 22.0 (IBM, Armonk, USA).
Results
BTS stenting was indicated in a total of 35 patients referred to us for colorectal stent placement. Of these patients, one underwent an emergency Hartmann's procedure for colonic perforation after stenting. BTS stenting was successful in 97.1% (34/35) of patients. Of these patients, we chose an open approach for the first eight patients because of lack of experience in safely performing laparoscopy in post-stent patients. One patient experienced a successful decompression of the intestine but could not undergo surgery because of progressive Alzheimer's disease. Twenty-five post-stent patients underwent elective laparoscopic resection at our institution during the study period. Excluding 10 patients who had combined procedures, we analyzed 15 patients who underwent elective laparoscopic surgery for left-sided colorectal cancer. The colorectal obstruction scoring system classification score was 0 in all patients before stent placement (13) . The interval from stent insertion to surgery was 21.5 AE 5.5 days. The decompression of the bowel after stent insertion was successful in all patients, and before surgery, each had a score of 4 on the colorectal obstruction scoring system classification. One grade I complication, paralytic ileus, was observed within 30 days of surgery. There was no conversion to open surgery, creation of a diverting stoma, or blood transfusion. Table 1 shows the comparison between laparoscopic colectomy after SEMS (stent-laparoscopy group) and regular laparoscopic colectomy for non-obstructive cancer (control group) during the same study period.
Patient characteristics were comparable between the groups. The stent-laparoscopy group had a larger tumor size and more blood loss than the control group, but the other perioperative outcomes were comparable. In the control group, four cases of superficial surgical site infections (SSIs) (all grade I) and three cases of paralytic ileus (one grade I, two grade II) were observed. There was no 30-day or inhospital mortality in either group. Furthermore, the number of retrieved lymph nodes did not differ between groups.
Discussion
The treatment strategy for acute malignant colonic obstruction depends on patient status and institutional practices. SEMS placement can provide the means for converting an emergent procedure into an elective one for patients at high risk of morbidity or mortality. Colonic stenting as a BTS for obstructive colorectal cancer patients helps improve nutritional status, mechanical bowel preparation, primary anastomosis without stoma creation, and even laparoscopic surgery.
Using a metallic stent for acute obstructive colorectal cancer has been well assessed and established as an effective procedure (10, 14) . SEMS were successfully inserted as a BTS in 97.1% of patients in our study. We performed elective open surgery after SEMS placement in the first eight cases of obstructive colon cancer and confirmed sufficient intestinal decompression after the stent was in place for 2-3 weeks. Laparoscopy was inconvenient if distended bowel loops were present due to malignant colonic obstruction (15) . Colonic obstruction is normally considered to be a contraindication for laparoscopic surgery because of the poor surgical field and high risk of injury to the bowel. However, stent insertion prior to surgery for malignant obstruction can create an adequate surgical view for performing laparoscopic surgery.
The use of laparoscopy after SEMS has been a topic of debate. Morino et al. first reported an approach to obstructive left-sided colon cancer involving stent decompression followed by laparoscopic resection (16). Balague et al. first suggested that the rigidity of the colonic segment containing the stent and tumor might contribute to more difficult bowel handling and dissection than usual, thus prolonging the surgical time (17) . Law et al. reported that laparoscopic mobilization was not particularly difficult and the amount of blood loss was low (18) . Several articles have reported that laparoscopic surgery after SEMS had short-term outcomes that were better than or comparable to those of open surgery after SEM (5, 8, 10, 11) . We think that the stent-laparoscopic procedure should be performed by skilled surgeons because the tumor size is larger than in non-obstructive cancer, and edema or invasion around the tumor can make the procedure complicated. Surgeons should ensure atraumatic handling of the bowel by blunt retraction, grasping the epiploic appendages, and using atraumatic graspers. Although laparoscopic resection for colorectal cancer is accepted for patients with advanced colorectal cancer (19) (20) (21) , the impact of stent insertion on the laparoscopic procedure has not been well investigated. Zhou et al. compared stent-laparoscopy (n = 14) with onestage laparoscopic resection for left-sided colorectal cancer without acute colorectal obstruction (n = 88) (11) . Surgical outcomes, including operation time, blood loss, bowel function recovery, postoperative complications, and postoperative hospital stay, were comparable between both groups; the conversion rates to open surgery were 12.5% and 8.3%, respectively. In this study, the short-term surgical outcomes of this advanced form of laparoscopic surgery were comparable, with the exception of greater blood loss, to those of regular laparoscopic surgery for patients with non-obstructive colorectal cancer, provided that an experienced surgeon and team performed the procedure. There was no need for a blood transfusion or temporary stoma in the stentlaparoscopy group. There was no conversion to open surgery, and the surgical quality of the lymphadenectomy via stent-laparoscopy was not inferior to regular laparoscopy in terms of the number of retrieved lymph nodes. Postoperative complications were observed in 6.7% of the stent-laparoscopy group and in 12.7% of the control group, without any grade III or higher complications. Laparoscopic surgery can be safely performed by an experienced surgeon in patients with obstructive colorectal cancer if intestinal decompression with SEMS is successful.
The reported oncological outcomes of elective surgery after SEMS have been inconsistent; some studies have showed no difference in survival between stent-elective surgery and emergency surgery (4, (22) (23) (24) , whereas others have suggested poorer recurrence-free or overall survival in patients with stent insertion before surgery (25) (26) (27) . The guideline from the European Society of Gastrointestinal Endoscopy does not recommend SEMS as a bridge to elective surgery as a standard treatment for curable patients with left-sided malignant colonic obstruction because stenting seems to affect oncologic safety (27) . However, a recent meta-analysis showed that a BTS did not compromise the long-term outcomes of colonic stent placement when compared to emergency surgery (28) . The present study was not designed to assess the long-term oncological outcomes, so further studies are necessary to compare the long-term results of elective stent-laparoscopic surgery with those of elective stent-open surgery in patients with obstructive colorectal cancer.
In conclusion, this study showed that laparoscopic surgery after SEMS placement in patients with obstructive colorectal cancer can be performed as safely as regular laparoscopic surgery for patients with non-obstructive colorectal cancer. The surgical methods discussed here may provide a safer and, therefore, preferable option to emergency or elective open surgery for the treatment of obstructive colorectal cancer.
